Stock Analysis

Fortnox And 2 Other Swedish Stocks That Could Be Undervalued

Published

As global markets continue to navigate economic uncertainties, the Swedish stock market has shown resilience with potential opportunities for discerning investors. In this article, we explore three Swedish stocks that could be undervalued, starting with Fortnox. Identifying undervalued stocks often involves looking at companies with strong fundamentals and growth potential that may not yet be fully appreciated by the market.

Top 10 Undervalued Stocks Based On Cash Flows In Sweden

NameCurrent PriceFair Value (Est)Discount (Est)
Sleep Cycle (OM:SLEEP)SEK40.70SEK80.1749.2%
QleanAir (OM:QAIR)SEK26.90SEK51.7548%
Stille (OM:STIL)SEK222.00SEK443.0049.9%
Paradox Interactive (OM:PDX)SEK139.40SEK259.1046.2%
Dometic Group (OM:DOM)SEK68.95SEK132.3447.9%
Nolato (OM:NOLA B)SEK53.70SEK99.0945.8%
Flexion Mobile (OM:FLEXM)SEK9.28SEK17.5747.2%
Tourn International (OM:TOURN)SEK8.38SEK16.4749.1%
Humble Group (OM:HUMBLE)SEK9.815SEK18.7147.5%
Nordisk Bergteknik (OM:NORB B)SEK18.80SEK36.8849%

Click here to see the full list of 43 stocks from our Undervalued Swedish Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener.

Fortnox (OM:FNOX)

Overview: Fortnox AB (publ) offers financial and administrative software solutions for small and medium-sized businesses, accounting firms, and organizations, with a market cap of SEK35.11 billion.

Operations: The company's revenue segments include Businesses (SEK378 million), Marketplaces (SEK160 million), Core Products (SEK734 million), Accounting Firms (SEK352 million), and Financial Services (SEK249 million).

Estimated Discount To Fair Value: 26.6%

Fortnox is trading at SEK 57.56, significantly below its estimated fair value of SEK 78.46, indicating it may be undervalued based on cash flows. Earnings are forecast to grow by 22.6% annually over the next three years, outpacing the Swedish market's growth rate of 16.1%. Recent earnings reports show strong performance with Q2 sales at SEK 515 million and net income rising to SEK 164 million from SEK 127 million a year ago.

OM:FNOX Discounted Cash Flow as at Aug 2024

Vimian Group (OM:VIMIAN)

Overview: Vimian Group AB (publ) operates in the global animal health industry and has a market cap of SEK20.45 billion.

Operations: The company's revenue segments are Medtech (€111.91 million), Diagnostics (€20.63 million), Specialty Pharma (€158.39 million), and Veterinary Services (€53.95 million).

Estimated Discount To Fair Value: 36.5%

Vimian Group, trading at SEK 39.15, is significantly undervalued based on cash flows with an estimated fair value of SEK 61.64. Despite recent shareholder dilution, the company's earnings are forecast to grow by 62.9% annually over the next three years, far outpacing the Swedish market's growth rate of 16.1%. Recent Q2 results show sales increased to EUR 90.99 million from EUR 81.31 million a year ago, with net income rising to EUR 4.87 million from EUR 2.99 million last year.

OM:VIMIAN Discounted Cash Flow as at Aug 2024

Yubico (OM:YUBICO)

Overview: Yubico AB provides authentication solutions for computers, networks, and online services with a market cap of SEK25.66 billion.

Operations: Yubico AB's revenue from Security Software & Services amounts to SEK2.09 billion.

Estimated Discount To Fair Value: 10.7%

Yubico (SEK298) is trading 10.7% below its estimated fair value of SEK333.73, indicating it may be undervalued based on cash flows. Despite recent shareholder dilution, Yubico's earnings are forecast to grow significantly at 43.69% annually over the next three years, outpacing the Swedish market's growth rate of 16.1%. Recent revenue grew by 21.2%, although profit margins declined from 17.8% to 9.3%. The company recently partnered with Straxis for a secure web browsing application for the U.S. Air Force.

OM:YUBICO Discounted Cash Flow as at Aug 2024

Next Steps

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com